Stock A140410 MEZZION PHARMA CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Mezzion Pharma Co.,Ltd.

Equities

A140410

KR7140410002

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
38,250 KRW -2.55% Intraday chart for Mezzion Pharma Co.,Ltd. +4.37% -1.92%
Mar. 18 Mezzion Pharma Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Mezzion Pharma Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

Mezzion Pharma Co., Ltd. is a Korea-based company engaged in the pharmaceutical business. The Company focuses on development and manufacture of remedies for erectile dysfunction and benign prostatic hyperplasia. In addition, the Company engages in the development of remedies for portal hypertension (PH), pulmonary arterial hypertension (PAH), overactive bladder (OAB), chronic obstructive pulmonary disease (COPD) and others. The Company has sighed licensing contract with overseas partners, including Warner in America, Valenta in Russia, Nycomed in Mexico and Dr.Falk in Europe. On April 22, 2013, the Company changed its name from Dong-A Pharmtech Co., Ltd. to Mezzion Pharma Co., Ltd.

Number of employees: 45

Sales per Business

KRW in Million2022Weight2023Weight Delta
BNF
100.0 %
30,726 100.0 % 31,721 100.0 % +3.24%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
30,726 100.0 % 31,721 100.0 % +3.24%

Managers

Managers TitleAgeSince
Dong-Hyun Park FOU
 Founder 67 02-09-24
James L. Yeager CTO
 Chief Tech/Sci/R&D Officer 77 04-12-31
Bill Breitenbach PRN
 Corporate Officer/Principal - 21-05-31
Dae-Shick Oh AUD
 Comptroller/Controller/Auditor 69 19-03-28

Members of the board

Members of the board TitleAgeSince
Mitchell Steiner BRD
 Director/Board Member 63 -
Dong-Hyun Park FOU
 Founder 67 02-09-24
James L. Yeager CTO
 Chief Tech/Sci/R&D Officer 77 04-12-31
Peter J. Manso BRD
 Director/Board Member 70 -
Jae-Seung Baek BRD
 Director/Board Member 71 16-03-17
Bon-Gwon Gu BRD
 Director/Board Member 57 -
Jeong-Seok Chae BRD
 Director/Board Member 68 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 29,699,621 21,201,688 ( 71.39 %) 0 71.39 %

Shareholders

NameEquities%Valuation
CCE Investment, Inc.
9.809 %
2,913,093 9.809 % 86 M ₩
Kayne Holdings LP
6.727 %
1,997,787 6.727 % 59 M ₩
Dong-Hyun Park
6.223 %
1,848,290 6.223 % 54 M ₩
Hye-soo Kim
2.894 %
859,533 2.894 % 25 M ₩
Glamour Box Ltd.
2.590 %
769,230 2.590 % 23 M ₩
Jae Hyung Kim
0.1010 %
30,000 0.1010 % 881 337 ₩
Kyung Wha Park
0.1010 %
30,000 0.1010 % 881 337 ₩
Korea Investment Management Co., Ltd.
0.0151 %
4,480 0.0151 % 131 613 ₩
Seong-il Noh
0.0108 %
3,200 0.0108 % 94 009 ₩
Mirae Asset Global Investments Co., Ltd.
0.000535 %
159 0.000535 % 4 671 ₩

Company contact information

Mezzion Pharma Co., Ltd.

7th Floor, Seokcheon Building 570, Samseong-ro

06163, Seoul

+

http://www.mezzion.co.kr
address Mezzion Pharma Co.,Ltd.(A140410)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
MEZZION PHARMA CO.,LTD. Stock Mezzion Pharma Co.,Ltd.
-1.92% 827M
MERCK KGAA Stock Merck KGaA
+5.17% 69.91B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+10.97% 9.03B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-17.03% 4.75B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+37.51% 4.31B
YUHAN CORPORATION Stock Yuhan Corporation
+3.92% 3.88B
INDIVIOR PLC Stock Indivior PLC
+18.50% 2.37B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-24.13% 2.26B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-29.70% 2.2B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+9.09% 1.98B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A140410 Stock
  4. Company Mezzion Pharma Co.,Ltd.